Paydirt
DL
Insider

David E. Lazar

Interim CEO

David E. Lazar (Interim CEO) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in CYCC. The largest single filing was $5.8M of CYCC (194,628,820 sh × $0.03, as filed), executed Feb 26 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.8M
shares × price, as filed
Last traded
Feb 26 2025
Filed Feb 28 2025
Open performance→
Volume by month
$5.8M$2.9M$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2025 · sells $5.8M
Buys $0 Sells $5.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 1 filing

Sector per market data · by filing · past 24 months

Most traded names
CYCC CYCC CYCC · 0 buys · 1 sell 1 filing
Recent filings
CYCCSALE Cyclacel Pharmaceuticals, Inc. View filing → $5.8M
194,628,820 sh × $0.03
Exec Feb 26 2025
Filed Feb 28 2025 · 5:30 PM ET